HEALTHY CHOICE WELLNESS CORP. (HCWC) EBITDA
- 2026-06-30: Basis Reported; EBITDA -$2.27M; Operating income (m); Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA -$1.24M; Operating income (m); Depreciation and amortization (m).
- 2025-12-31: Basis Reported; EBITDA -$1.02M; Operating income (m); Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA -$177,375.00; Operating income (m); Depreciation and amortization (m).
Complete source-backed ebitda history.
- Available history
- 2024-06-30 to 2026-06-30
- Data captured
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-06-30 | Reported | -$2.27M | (m) | (m) | (m) | -13.64% | $148.80K* | -$1.00M* | (m) | (m) | (m) | (m) |
|---|
| 2026-03-31 | Reported | -$1.24M | (m) | (m) | (m) | -6.77% | $71.42K | -$199.62K | (m) | (m) | $8.55M | (m) |
|---|
| 2025-12-31 | Reported | -$1.02M | (m) | (m) | (m) | -5.44% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2025-09-30 | Reported | -$177,375.00 | (m) | (m) | (m) | -0.93% | $42.68K* | -$308.65K* | (m) | (m) | $8.00M | (m) |
|---|
| 2025-06-30 | Reported | $395,685.00 | (m) | (m) | (m) | 1.96% | $78.47K* | $1.07M* | (m) | (m) | (m) | (m) |
|---|
| 2025-03-31 | Reported | $20,235.00 | (m) | (m) | (m) | 0.10% | $127.42K | $1.09M | (m) | (m) | $8.26M | (m) |
|---|
| 2024-12-31 | Reported | $106,549.00 | (m) | (m) | (m) | 0.54% | (m) | (m) | (m) | (m) | (m) | (m) |
|---|
| 2024-09-30 | Reported | $50,777.00 | (m) | (m) | (m) | 0.28% | $28.70K* | -$962.98K* | (m) | (m) | $7.58M | (m) |
|---|
| 2024-06-30 | Reported | -$119,741.00 | (m) | (m) | (m) | -0.77% | $42.76K* | -$452.77K* | (m) | (m) | (m) | (m) |
|---|
| 2024-03-31 | Reported | (m) | -$601.75K | (m) | $15.89M | (m) | $74.22K | -$2.55M | (m) | (m) | (m) | (m) |
|---|
| 2023-09-30 | Reported | (m) | -$1.26M | (m) | $12.70M | (m) | (m) | (m) | (m) | (m) | $5.90M | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2025-12-31 | Reported | -$779,909.00 | (m) | (m) | (m) | -1.00% | $320.63K | $996.05K | (m) | (m) | $33.14M | (m) |
|---|
| 2024-12-31 | Reported | -$201,021.00 | (m) | (m) | (m) | -0.29% | $251.79K | -$3.06M | (m) | (m) | $29.05M | (m) |
|---|
| 2023-12-31 | Reported | (m) | -$10.52M | (m) | $55.69M | (m) | $179.62K | -$2.53M | (m) | (m) | $24.77M | (m) |
|---|